Leela Prasad Kowtharapu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Leela Prasad Kowtharapu has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Naresh Kumar Katari
School of Chemistry & Physics, College of Agriculture, Engineering & Science, Westville Campus University of KwaZulu‐Natal Durban South Africa
16 shared publications - Rambabu Gundla
Department of Chemistry, School of Science, GITAM University, Hyderabad 502102, Telangana, India
8 shared publications - Naresh Konduru
Department of Chemistry GITAM School of Science GITAM Deemed to be University Visakhapatnam India
7 shared publications - Siva Krishna Muchakayala
Department of Chemistry, School of Science, GITAM Deemed to be University, Hyderabad-502329, India
4 shared publications - Christian A. Sandoval
Shenzhen DEC Pharmaceutical Co., Ltd, Analytical Development Department , Shenzhen, China
3 shared publications Girish K. Deshpande
Department of Chemistry GITAM School of Science GITAM Deemed to be University Visakhapatnam India
3 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by Elsevier in SSRN Electronic Journal
Development of Green and Sustainable LC–MS Method for Trace-level Determination of N-Nitroso Vildagliptin in the DPP-4 Inhibitor Vildagliptin
This study reports the development and validation of an efficient, green and sustainable liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the detection and quantification of a potential nitrosated drug substance impurity N-Nitroso vildagliptin (NV) from vildagliptin (VG) API. The method is highly sensitive and selective for the determination of NV. Separations were achieved using Sunfire C18 column (150 mm × 4.6 mm, 3.5 µm) with gradient elution. Mobile phase A was 5.0 mM ammonium formate and mobile phase B was methanol. The flow rate was set at 0.6 mL/min. Quantitative data were acquired in multi reaction monitoring (MRM) mode to increase the selectivity and sensitivity of the bioanalytical method. Limit of detection (LOD) and limit of quantification (LOQ) were found to be 0.5 and 1.5 ng/mL which suggest that the method is highly sensitive. Accuracy estimates for LOQ spiked samples were within the range of 80%-120% and those for the 50, 100, and 150% spiked samples were within 85%-115%. The environmental impact of the current analytical procedure was assessed using four green analytical methods; AGREE metrics, Modified Green Analytical Procedure Index (MoGAPI), Analytical Eco-Scale and National Environmental Methods Index (NEMI). An Eco-Score of 79, a MoGAPI score of 72 and an AGREE score of 0.6 were obtained which implies that the analytical procedure is environmentally benign and performs very well. The developed and validated LC-MS/MS method is efficient for routine analysis of NV in VG pharmaceutical products due to its sensitivity and selectivity as well as being eco-friendly.
- 16 October 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDevelopment of Green and Sustainable LC–MS Method for Trace-level Determination of N-Nitroso Vildagliptin in the DPP-4 Inhibitor Vildagliptin
This study reports the development and validation of an efficient, green and sustainable liquid chromatography tandem mass spectrometry (LC-MS/MS) method for the detection and quantification of a potential nitrosated drug substance impurity N-Nitroso vildagliptin (NV) from vildagliptin (VG) API. The method is highly sensitive and selective for the determination of NV. Separations were achieved using Sunfire C18 column (150 mm × 4.6 mm, 3.5 µm) with gradient elution. Mobile phase A was 5.0 mM ammonium formate and mobile phase B was methanol. The flow rate was set at 0.6 mL/min. Quantitative data were acquired in multi reaction monitoring (MRM) mode to increase the selectivity and sensitivity of the bioanalytical method. Limit of detection (LOD) and limit of quantification (LOQ) were found to be 0.5 and 1.5 ng/mL which suggest that the method is highly sensitive. Accuracy estimates for LOQ spiked samples were within the range of 80%-120% and those for the 50, 100, and 150% spiked samples were within 85%-115%. The environmental impact of the current analytical procedure was assessed using four green analytical methods; AGREE metrics, Modified Green Analytical Procedure Index (MoGAPI), Analytical Eco-Scale and National Environmental Methods Index (NEMI). An Eco-Score of 79, a MoGAPI score of 72 and an AGREE score of 0.6 were obtained which implies that the analytical procedure is environmentally benign and performs very well. The developed and validated LC-MS/MS method is efficient for routine analysis of NV in VG pharmaceutical products due to its sensitivity and selectivity as well as being eco-friendly.
- 29 September 2026
- Published by Wiley in Separation Science Plus
- Vol. 9 (10) , e70322
Eco‐Friendly LC–MS/MS Determination of N ‐Nitroso Vildagliptin Amide, a Nitrosamine Carcinogenic Impurity, in Vildagliptin Drug Substance Using Advanced Greenness Metrics
In the process of making vildagliptin (VG) API, one of the nitrosamine groups found in the drug is N ‐nitroso vildagliptin amide (NVA). This led to the development of a multi‐reaction monitoring (MRM) approach that is both sensitive and reliable for quantitatively assessing NVA impurity in VG API. Using isocratic eluent conditions, the Shim‐pack GIST C18 column (250 mm × 4.6 mm, 5 µm) was used to separate VG and NVA. The mobile phase utilized in this study was a mixture of 0.1% formic acid in water and methanol in a ratio of 65:35 v/v. With a flow rate of 0.8 mL/min, the mobile phase runs. The transition for NVA's MRM is 351.00 > 115.30 at a collision energy of −11.0 eV. In this study, the values of 0.5 and 1.5 ppb, respectively, were used to verify the limits of detection and quantification for NVA impurity. The findings showed an accuracy level between 80% and 120% for limit of quantification (LOQ)‐spiked samples and 85%–115% for 50%, 100%, and 150% spiked samples. Ultimately, the devised technique of liquid chromatography tandem mass spectrometry provides an accurate, linear, appropriate, and exact way to assess the NVA impurity in the VG API. Several environmental impact evaluation tools were used to determine how eco‐friendly this method is. These included the analytical eco‐scale, the analytical greenness (AGREE) tool, the AGREE metric approach, the national environmental method index (NEMI), and the modified green analytical procedure index (MoGAPI). The devised approach has an Eco‐Scale score of 73, MoGAPI score of 72, and an AGREE score of 0.6.
- 29 September 2026
- Published by Wiley in Separation Science Plus
- Vol. 9 (10) , e70322
Eco‐Friendly LC–MS/MS Determination of N ‐Nitroso Vildagliptin Amide, a Nitrosamine Carcinogenic Impurity, in Vildagliptin Drug Substance Using Advanced Greenness Metrics
In the process of making vildagliptin (VG) API, one of the nitrosamine groups found in the drug is N ‐nitroso vildagliptin amide (NVA). This led to the development of a multi‐reaction monitoring (MRM) approach that is both sensitive and reliable for quantitatively assessing NVA impurity in VG API. Using isocratic eluent conditions, the Shim‐pack GIST C18 column (250 mm × 4.6 mm, 5 µm) was used to separate VG and NVA. The mobile phase utilized in this study was a mixture of 0.1% formic acid in water and methanol in a ratio of 65:35 v/v. With a flow rate of 0.8 mL/min, the mobile phase runs. The transition for NVA's MRM is 351.00 > 115.30 at a collision energy of −11.0 eV. In this study, the values of 0.5 and 1.5 ppb, respectively, were used to verify the limits of detection and quantification for NVA impurity. The findings showed an accuracy level between 80% and 120% for limit of quantification (LOQ)‐spiked samples and 85%–115% for 50%, 100%, and 150% spiked samples. Ultimately, the devised technique of liquid chromatography tandem mass spectrometry provides an accurate, linear, appropriate, and exact way to assess the NVA impurity in the VG API. Several environmental impact evaluation tools were used to determine how eco‐friendly this method is. These included the analytical eco‐scale, the analytical greenness (AGREE) tool, the AGREE metric approach, the national environmental method index (NEMI), and the modified green analytical procedure index (MoGAPI). The devised approach has an Eco‐Scale score of 73, MoGAPI score of 72, and an AGREE score of 0.6.
- 17 June 2026
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 109 (6) , 906-916
Quantification of 24 inorganic impurities in vismodegib and idelalisib anticancer drug substances using ICP-MS
Background: Metal impurities in pharmaceutical products can originate from various sources, including manufacturing machinery, catalysts used during drug synthesis, and even the container-closure systems. Objective: The objective of the present study is to accurately quantify trace levels of 24 metal impurities in the active pharmaceutical ingredients (APIs) of the anticancer drugs vismodegib and idelalisib using inductively coupled plasma-mass spectrometry. Methods: The diluent used in the analysis consists of a mixture of 3% nitric acid and 1% hydrochloric acid, while argon serves as the carrier gas. Helium is utilized as the collision gas at a flow rate of 4.3 mL/min. The plasma gas flow rate is maintained at 16 L/min, and the spray chamber temperature is controlled at 2°C to ensure optimal stability during analysis. The dwell time for each metal impurity is set to 0.3 s, and the instrument is precisely tuned in helium mode to achieve accurate and interference-free detection of trace metal impurities. Results: No interference was observed from the calibration blanks, confirming the method’s selectivity and accuracy. The sample recoveries were satisfactory, falling within the United States Pharmacopeia (USP) acceptance range of 70–150%. Conclusion: The analytical procedure was performed in accordance with USP and International Council for Harmonisation (ICH) Q3D(R2) guidelines, and all results were found to be within the established acceptance criteria, thereby validating the reliability and compliance of the method. Highlights: To date, no research studies have been reported on the determination of 24 elemental metal impurities in the drug substances vismodegib and idelalisib. Therefore, the present research develops a unified and reliable analytical method for the quantification of these metal impurities in the active pharmaceutical ingredients (APIs) of both drugs, ensuring compliance with regulatory standards and enhancing the overall quality and safety of the pharmaceutical products. Vismodegib, Idelalisib, ICH Q3D(R2), USP, ICPMS, Toxic metal impurities
- 17 June 2026
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 109 (6) , 906-916
Quantification of 24 inorganic impurities in vismodegib and idelalisib anticancer drug substances using ICP-MS
Background: Metal impurities in pharmaceutical products can originate from various sources, including manufacturing machinery, catalysts used during drug synthesis, and even the container-closure systems. Objective: The objective of the present study is to accurately quantify trace levels of 24 metal impurities in the active pharmaceutical ingredients (APIs) of the anticancer drugs vismodegib and idelalisib using inductively coupled plasma-mass spectrometry. Methods: The diluent used in the analysis consists of a mixture of 3% nitric acid and 1% hydrochloric acid, while argon serves as the carrier gas. Helium is utilized as the collision gas at a flow rate of 4.3 mL/min. The plasma gas flow rate is maintained at 16 L/min, and the spray chamber temperature is controlled at 2°C to ensure optimal stability during analysis. The dwell time for each metal impurity is set to 0.3 s, and the instrument is precisely tuned in helium mode to achieve accurate and interference-free detection of trace metal impurities. Results: No interference was observed from the calibration blanks, confirming the method’s selectivity and accuracy. The sample recoveries were satisfactory, falling within the United States Pharmacopeia (USP) acceptance range of 70–150%. Conclusion: The analytical procedure was performed in accordance with USP and International Council for Harmonisation (ICH) Q3D(R2) guidelines, and all results were found to be within the established acceptance criteria, thereby validating the reliability and compliance of the method. Highlights: To date, no research studies have been reported on the determination of 24 elemental metal impurities in the drug substances vismodegib and idelalisib. Therefore, the present research develops a unified and reliable analytical method for the quantification of these metal impurities in the active pharmaceutical ingredients (APIs) of both drugs, ensuring compliance with regulatory standards and enhancing the overall quality and safety of the pharmaceutical products. Vismodegib, Idelalisib, ICH Q3D(R2), USP, ICPMS, Toxic metal impurities
- Open Access
- 8 June 2026
- Published by Elsevier in SSRN Electronic Journal
A Sustainable LC–MS Method for Determination of Genotoxic Impurity 1-(2-chloroacetyl)pyrrolidine-2-carboxamide (CAPCA): Assessment by Advanced Green Analytical Metrics
This study details the process of creating and testing a sensitive and selective LC-MS/MS method that can detect and quantify the possible genotoxic impurity 1-(2-chloroacetyl)pyrrolidine-2-carboxamide (CAPCA) in Vildagliptin active pharmaceutical ingredient (API). CAPCA is an unwanted byproduct of the vildagliptin production process that has the ability to interact with DNA and produce genotoxic consequences due to its electrophilic functional group. This makes it a possible regulatory issue. The Hypersil BDS C18 column (250 mm × 4.6 mm, 5 µm) was used for chromatographic separation with isocratic elution. The mobile phases A and B were 0.1% formic acid in water and methanol, respectively, and the flow rate was 0.8 mL/min. To make sure the quantitative analysis was more sensitive and selective, it was run in multiple reaction monitoring (MRM) mode. With a limit of detection (LOD) of 0.5 ng/mL and a limit of quantification (LOQ) of 1.5 ng/mL, the created technique demonstrated remarkable sensitivity. Conforming to the acceptance criteria outlined by International Council of Harmonization (ICH) and United States Pharmacopeia (USP) standards, the method was determined to have an accuracy range of 70-130%. The analytical procedure's environmental sustainability was further investigated utilizing four green analytical evaluation tools: the AGREE metrics, the Modified Green Analytical Procedure Index (MoGAPI), the Analytical Eco-Scale, and the National Environmental Methods Index (NEMI). An Eco-Scale score of 67 and an AGREE score of 0.62 showed that the procedure was environmentally friendly and performed adequately. The validated LC-MS/MS approach is well-suited for regular monitoring of CAPCA in Vildagliptin pharmacological compounds due to its high sensitivity, specificity, and ecologically sustainable profile.
- 8 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessA Sustainable LC–MS Method for Determination of Genotoxic Impurity 1-(2-chloroacetyl)pyrrolidine-2-carboxamide (CAPCA): Assessment by Advanced Green Analytical Metrics
This study details the process of creating and testing a sensitive and selective LC-MS/MS method that can detect and quantify the possible genotoxic impurity 1-(2-chloroacetyl)pyrrolidine-2-carboxamide (CAPCA) in Vildagliptin active pharmaceutical ingredient (API). CAPCA is an unwanted byproduct of the vildagliptin production process that has the ability to interact with DNA and produce genotoxic consequences due to its electrophilic functional group. This makes it a possible regulatory issue. The Hypersil BDS C18 column (250 mm × 4.6 mm, 5 µm) was used for chromatographic separation with isocratic elution. The mobile phases A and B were 0.1% formic acid in water and methanol, respectively, and the flow rate was 0.8 mL/min. To make sure the quantitative analysis was more sensitive and selective, it was run in multiple reaction monitoring (MRM) mode. With a limit of detection (LOD) of 0.5 ng/mL and a limit of quantification (LOQ) of 1.5 ng/mL, the created technique demonstrated remarkable sensitivity. Conforming to the acceptance criteria outlined by International Council of Harmonization (ICH) and United States Pharmacopeia (USP) standards, the method was determined to have an accuracy range of 70-130%. The analytical procedure's environmental sustainability was further investigated utilizing four green analytical evaluation tools: the AGREE metrics, the Modified Green Analytical Procedure Index (MoGAPI), the Analytical Eco-Scale, and the National Environmental Methods Index (NEMI). An Eco-Scale score of 67 and an AGREE score of 0.62 showed that the procedure was environmentally friendly and performed adequately. The validated LC-MS/MS approach is well-suited for regular monitoring of CAPCA in Vildagliptin pharmacological compounds due to its high sensitivity, specificity, and ecologically sustainable profile.
- Open Access
- 28 September 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (39) , 44885-44894
Quality-by-Design-Driven RP-HPLC Method Development and Validation for Impurity Analysis of Elexacaftor, a Cystic Fibrosis Drug, with LC-MS/MS-Based Degradant Identification
The development and validation of an analytical technique based on RP-HPLC for the determination of impurities in Elexacaftor (ELX). Using a straightforward and stability-indicating HPLC technique, six known contaminants were precisely assessed with the right resolutions and peak forms. In a number of separation studies, the chromatographic separation was accomplished using an XBridge Shield RP 18, 150 mm × 4.6 mm, 3.5 μm column. The mobile phases consisted of methanol, acetonitrile, 2-propanol, and 10 mM potassium dihydrogen orthophosphate buffer used for the analysis. The gradient elution process took 90 min to complete, and the column temperature was 27 °C. Photodiode array optimization was accomplished at 220 nm with a 0.7 mL/min flow rate. The developed procedure was validated following ICH requirements and discovered to be robust, linear, accurate, specific, selective, and exact. The method range extended from LOQ to ∼0.45% for impurities and LOQ to ∼120% for the Elexacaftor drug substance. The method robustness was established by utilizing the DoEs in the part of the QbD concept. The method’s stability was evaluated under diverse conditions including acid and base hydrolysis, oxidative and water hydrolysis, and thermal and photolytic degradation and was helpful for process development as well as quality checks in bulk drug manufacturing.
- 28 September 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (39) , 44885-44894
Open AccessQuality-by-Design-Driven RP-HPLC Method Development and Validation for Impurity Analysis of Elexacaftor, a Cystic Fibrosis Drug, with LC-MS/MS-Based Degradant Identification
The development and validation of an analytical technique based on RP-HPLC for the determination of impurities in Elexacaftor (ELX). Using a straightforward and stability-indicating HPLC technique, six known contaminants were precisely assessed with the right resolutions and peak forms. In a number of separation studies, the chromatographic separation was accomplished using an XBridge Shield RP 18, 150 mm × 4.6 mm, 3.5 μm column. The mobile phases consisted of methanol, acetonitrile, 2-propanol, and 10 mM potassium dihydrogen orthophosphate buffer used for the analysis. The gradient elution process took 90 min to complete, and the column temperature was 27 °C. Photodiode array optimization was accomplished at 220 nm with a 0.7 mL/min flow rate. The developed procedure was validated following ICH requirements and discovered to be robust, linear, accurate, specific, selective, and exact. The method range extended from LOQ to ∼0.45% for impurities and LOQ to ∼120% for the Elexacaftor drug substance. The method robustness was established by utilizing the DoEs in the part of the QbD concept. The method’s stability was evaluated under diverse conditions including acid and base hydrolysis, oxidative and water hydrolysis, and thermal and photolytic degradation and was helpful for process development as well as quality checks in bulk drug manufacturing.
- 13 July 2024
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 107 (6) , 921-933
Headspace Gas Chromatography–Mass Spectrometry Method for Determination of Class-I Residual Solvents in Several Drug Substances: Method Evaluation by Quality by Design Statistical Tool
Background: Class-I residual solvents such as 1,1-dichloroethene, 1,1,1-trichloroethane, carbon tetrachloride, benzene, 1,2-dichloroethane are toxic, environmental hazards, and carcinogenic to humans. A headspace-gas chromatography–mass spectrometer is a sophisticated instrument for the quantification of residual solvents at lower limits. Objective: An exact, sensitive, reliable, and fast method was developed to determine 1,1-dichloroethene, 1,1,1-trichloroethane, carbon tetrachloride, benzene, and 1,2-dichloroethane present in different drug substances using a headspace-gas chromatography–mass spectrometer. Methods: Helium is used as a carrier gas. N-methyl-2-pyrrolidone is used as a diluent, and the stationary phase is a DB-624 (60 m × 0.25 mm × 1.4 μm film thickness) column with a flow rate of 1.5 mL/min. Results: The concentration LODs for 1,1-dichloroethene, 1,1,1-trichloroethane, carbon tetrachloride, benzene, and 1,2-dichloroethane were 0.24, 5, 0.12, 0.06, and 0.15 ppm. The concentrations LOQs for the aforementioned impurities were 0.8, 15, 0.4, 0.2, and 0.5 ppm. The linearity was assessed over the range from LOQ to 120% of the specification level. Conclusion: The current method's system suitability, precision, linearity, and accuracy parameters were assessed in accordance with the United states pharmacopeia (USP) < 1225> and International Conference on Harmonization of technical standards for the registration of medicines for human use (ICH) Q2(R2), and the results were within the acceptance criteria. Highlights: No research studies have been reported on determining class-I residual solvents in lincomycin hydrochloride, dapagliflozin, vonoprazan fumarate, and telmisartan drug substances. The proposed research aims to develop a common method for the quantification of class-I residual solvents for drug substances. The quality by design (QbD) concept is utilized in performance verification.
- 13 July 2024
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 107 (6) , 921-933
Headspace Gas Chromatography–Mass Spectrometry Method for Determination of Class-I Residual Solvents in Several Drug Substances: Method Evaluation by Quality by Design Statistical Tool
Background: Class-I residual solvents such as 1,1-dichloroethene, 1,1,1-trichloroethane, carbon tetrachloride, benzene, 1,2-dichloroethane are toxic, environmental hazards, and carcinogenic to humans. A headspace-gas chromatography–mass spectrometer is a sophisticated instrument for the quantification of residual solvents at lower limits. Objective: An exact, sensitive, reliable, and fast method was developed to determine 1,1-dichloroethene, 1,1,1-trichloroethane, carbon tetrachloride, benzene, and 1,2-dichloroethane present in different drug substances using a headspace-gas chromatography–mass spectrometer. Methods: Helium is used as a carrier gas. N-methyl-2-pyrrolidone is used as a diluent, and the stationary phase is a DB-624 (60 m × 0.25 mm × 1.4 μm film thickness) column with a flow rate of 1.5 mL/min. Results: The concentration LODs for 1,1-dichloroethene, 1,1,1-trichloroethane, carbon tetrachloride, benzene, and 1,2-dichloroethane were 0.24, 5, 0.12, 0.06, and 0.15 ppm. The concentrations LOQs for the aforementioned impurities were 0.8, 15, 0.4, 0.2, and 0.5 ppm. The linearity was assessed over the range from LOQ to 120% of the specification level. Conclusion: The current method's system suitability, precision, linearity, and accuracy parameters were assessed in accordance with the United states pharmacopeia (USP) < 1225> and International Conference on Harmonization of technical standards for the registration of medicines for human use (ICH) Q2(R2), and the results were within the acceptance criteria. Highlights: No research studies have been reported on determining class-I residual solvents in lincomycin hydrochloride, dapagliflozin, vonoprazan fumarate, and telmisartan drug substances. The proposed research aims to develop a common method for the quantification of class-I residual solvents for drug substances. The quality by design (QbD) concept is utilized in performance verification.
- 6 June 2024
- Published by Wiley in Biomedical Chromatography
- Vol. 38 (8) , e5920
Gas chromatography mass spectrometer determination of dimethylamine impurity in N,N‐dimethylformamide solvent by derivatization of N,N‐dimethylbenzamide with benzoyl chloride agent
This study describes the development of a reliable and linear analytical method for precisely determining dimethylamine impurity in N,N‐dimethylformamide solvent utilizing a benzoyl chloride derivatization reagent and a gas chromatography mass spectrometer. Benzoyl chloride was used to derivatize dimethylamine. At normal temperature, benzoyl chloride combined with dimethylamine, producing N,N‐dimethylbenzamide. This method separated N,N‐dimethylbenzamide using Rtx‐5 amine (30 m × 0.32 mm × 1.50 μm) as the stationary phase, helium as the carrier gas, argon as the collision gas, and methanol as the diluent. The column flow rate was 2 mL/min. The retention time of N,N‐dimethylbenzamide was determined to be 8.5 min. Precision, linearity, and accuracy were tested using ICH Q2 (R2) and USP guidelines. The percentage coefficient of variation (CV) for N,N‐dimethylbenzamide in the system suitability parameter was 1.1%. The correlation coefficient of N,N‐dimethylbenzamide was found to be >0.99. In the method precision parameter, the % CV for N,N‐dimethylbenzamide was found to be 1.9%, whereas the % CV for N,N‐dimethylbenzamide was 1.2% in intermediate precision. The percentage recovery of N,N‐dimethylbenzamide was determined to be between 80% and 98%.
- 6 June 2024
- Published by Wiley in Biomedical Chromatography
- Vol. 38 (8) , e5920
Gas chromatography mass spectrometer determination of dimethylamine impurity in N,N‐dimethylformamide solvent by derivatization of N,N‐dimethylbenzamide with benzoyl chloride agent
This study describes the development of a reliable and linear analytical method for precisely determining dimethylamine impurity in N,N‐dimethylformamide solvent utilizing a benzoyl chloride derivatization reagent and a gas chromatography mass spectrometer. Benzoyl chloride was used to derivatize dimethylamine. At normal temperature, benzoyl chloride combined with dimethylamine, producing N,N‐dimethylbenzamide. This method separated N,N‐dimethylbenzamide using Rtx‐5 amine (30 m × 0.32 mm × 1.50 μm) as the stationary phase, helium as the carrier gas, argon as the collision gas, and methanol as the diluent. The column flow rate was 2 mL/min. The retention time of N,N‐dimethylbenzamide was determined to be 8.5 min. Precision, linearity, and accuracy were tested using ICH Q2 (R2) and USP guidelines. The percentage coefficient of variation (CV) for N,N‐dimethylbenzamide in the system suitability parameter was 1.1%. The correlation coefficient of N,N‐dimethylbenzamide was found to be >0.99. In the method precision parameter, the % CV for N,N‐dimethylbenzamide was found to be 1.9%, whereas the % CV for N,N‐dimethylbenzamide was 1.2% in intermediate precision. The percentage recovery of N,N‐dimethylbenzamide was determined to be between 80% and 98%.
- 22 December 2023
- Published by Wiley in Journal of Separation Science
- Vol. 47 (1) , e2300760
A quality‐by‐design evaluated liquid chromatography method development and validation for the separation and quantification of nitroxoline and its impurities
A novel, isocratic, sensitive, stability‐indicating high‐performance liquid chromatography method was developed for the separation and quantification of related substances in nitroxoline (NTL). The chromatographic separation has been achieved on Inertsil ODS‐3 V, (250 × 4.6 mm, 5 μm) at 240 nm using ethylenediamine tetraacetic acid buffer and methanol in the ratio of 60:40 v/v as mobile phase. The performance of the method has been checked as per the International Conference on Harmonization guidelines for specificity, linearity, accuracy, precision, and robustness. Regression analysis showed a correlation coefficient value greater than 0.99 for NTL and its three impurities. The detection limit of impurities was in the range of 0.01% (0.05 μg/mL)–0.22% (1.1 μg/mL) indicating the sensitivity of the newly developed method. The accuracy of the method was established based on the recovery obtained between 94.7% and 104.1% for all the impurities. The percentage relative standard deviation obtained for the repeatability was less than 4.0% at the specification level for all impurities. Forced degradation was performed to establish the stability‐indicating nature of the method and to know about the degradation products, the quality of a drug substance changes with time under the influence of stress conditions. Thus, the proposed method was validated and found to be specific, sensitive, linear, accurate, precise, reproducible, and beneficial for routine usage.
- 22 December 2023
- Published by Wiley in Journal of Separation Science
- Vol. 47 (1) , e2300760
A quality‐by‐design evaluated liquid chromatography method development and validation for the separation and quantification of nitroxoline and its impurities
A novel, isocratic, sensitive, stability‐indicating high‐performance liquid chromatography method was developed for the separation and quantification of related substances in nitroxoline (NTL). The chromatographic separation has been achieved on Inertsil ODS‐3 V, (250 × 4.6 mm, 5 μm) at 240 nm using ethylenediamine tetraacetic acid buffer and methanol in the ratio of 60:40 v/v as mobile phase. The performance of the method has been checked as per the International Conference on Harmonization guidelines for specificity, linearity, accuracy, precision, and robustness. Regression analysis showed a correlation coefficient value greater than 0.99 for NTL and its three impurities. The detection limit of impurities was in the range of 0.01% (0.05 μg/mL)–0.22% (1.1 μg/mL) indicating the sensitivity of the newly developed method. The accuracy of the method was established based on the recovery obtained between 94.7% and 104.1% for all the impurities. The percentage relative standard deviation obtained for the repeatability was less than 4.0% at the specification level for all impurities. Forced degradation was performed to establish the stability‐indicating nature of the method and to know about the degradation products, the quality of a drug substance changes with time under the influence of stress conditions. Thus, the proposed method was validated and found to be specific, sensitive, linear, accurate, precise, reproducible, and beneficial for routine usage.
- Open Access
- 28 September 2023
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 35 (10) , 2353-2358
Evaluation of Physico-Chemical Properties Influence on Drug Product in vitro Profiles and Solubility Profile of Fourth Generation Antibacterial Drug
Moxifloxacin hydrochloride drug substance used to treat bacterial infections in many different parts of the body and most widely used worldwide. In this study, various high-end physico-chemical techniques are used like PXRD, DSC, TGA, BET SSA and PSD analysis to check the relative differences on the product behaviour. The present work reports an impact of alteration in particle size due to compaction process where increase in particle size has been observed from 15.912 μm to 751.001 μm, decrease in specific surface area from 1.89 m2/g to 0.861 m2/g, decrease in crystallinity from 91.65% to 59.15% and impact of dehydration or loss of water from 3.776% to 1.866%, which were observed during study. All the alterations in the physico-chemical properties impacting the drug manufacturing process and on the bioperformance of the finished product. This research attempt aims to investigate the effects of these modifications on in vitro experiments conducted in the office of generic drugs (OGD) media and the equilibrium solubility profile. The in vitro studies resulted about 35% release difference observed in the initial time points, whereas solubility in water observed about 17 mg/mL difference. This research work helps to demonstrate the optimization of finished product development process to meet the biofriendly formulation.
- 28 September 2023
- Published by Asian Publication Corporation in Asian Journal of Chemistry
- Vol. 35 (10) , 2353-2358
Open AccessEvaluation of Physico-Chemical Properties Influence on Drug Product in vitro Profiles and Solubility Profile of Fourth Generation Antibacterial Drug
Moxifloxacin hydrochloride drug substance used to treat bacterial infections in many different parts of the body and most widely used worldwide. In this study, various high-end physico-chemical techniques are used like PXRD, DSC, TGA, BET SSA and PSD analysis to check the relative differences on the product behaviour. The present work reports an impact of alteration in particle size due to compaction process where increase in particle size has been observed from 15.912 μm to 751.001 μm, decrease in specific surface area from 1.89 m2/g to 0.861 m2/g, decrease in crystallinity from 91.65% to 59.15% and impact of dehydration or loss of water from 3.776% to 1.866%, which were observed during study. All the alterations in the physico-chemical properties impacting the drug manufacturing process and on the bioperformance of the finished product. This research attempt aims to investigate the effects of these modifications on in vitro experiments conducted in the office of generic drugs (OGD) media and the equilibrium solubility profile. The in vitro studies resulted about 35% release difference observed in the initial time points, whereas solubility in water observed about 17 mg/mL difference. This research work helps to demonstrate the optimization of finished product development process to meet the biofriendly formulation.
- 27 September 2023
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 107 (1) , 31-39
Quantification of Drospirenone- and Ethinyl Estradiol-Related Impurities in a Combined Pharmaceutical Dosage Form by a Chromatography Method With a QbD Robustness Study
Background: The estimation of drugs containing drospirenone (DRSP) and ethinyl estradiol (EE), and their related impurities, in low-dose oral contraceptive drug products is an extremely challenging target. The proposed research sought to develop and validate a stability-indicating method for quantifying drug substances and their related impurities in tablet formulation. Objective: To develop and validate a simple, specific, accurate, precise, and stability-indicating reverse-phase (RP)-HPLC method for quantification of DRSP, EE, and their impurities in accordance with International Conference on Harmonisation (ICH) guidelines. Method: The separation was achieved using an Agilent Zorbax SB C18 column (4.6 mm × 250 mm, 5 µm) with a detection wavelength of 215 nm and mobile phases A (100% acetonitrile) and B (acetonitrile–water, 1 + 3, v/v) at a flow rate of 1.3 mL/min and a column temperature of 40°C. Results: The recovery study of each impurity was conducted in the range of 24 to 72 µg/mL for DRSP-related impurities and 0.2 to 0.6 µg/mL for EE-related impurities with respect to the specification limit. A linearity study was conducted over a range of 1.5 to 90 µg/mL for DRSP and DRSP-related impurities, and 0.125 to 0.75 µg/mL for EE-related impurities. A Quality by Design (QbD) study demonstrated the method’s robustness. Conclusions: As per current guidelines, a stability-indicating method has been developed for the determination of impurities in DRSP/EE film-coated tablets. A QbD-based robustness test was performed and the method was found to be robust. Highlights: An accurate, precise, stability-indicating, gradient RP-HPLC method has been developed and validated to determine DRSP, EE, and nine related impurities in tablet formulation. A QbD technique was used to establish a robustness study.
- 27 September 2023
- Published by Oxford University Press (OUP) in Journal of AOAC INTERNATIONAL
- Vol. 107 (1) , 31-39
Quantification of Drospirenone- and Ethinyl Estradiol-Related Impurities in a Combined Pharmaceutical Dosage Form by a Chromatography Method With a QbD Robustness Study
Background: The estimation of drugs containing drospirenone (DRSP) and ethinyl estradiol (EE), and their related impurities, in low-dose oral contraceptive drug products is an extremely challenging target. The proposed research sought to develop and validate a stability-indicating method for quantifying drug substances and their related impurities in tablet formulation. Objective: To develop and validate a simple, specific, accurate, precise, and stability-indicating reverse-phase (RP)-HPLC method for quantification of DRSP, EE, and their impurities in accordance with International Conference on Harmonisation (ICH) guidelines. Method: The separation was achieved using an Agilent Zorbax SB C18 column (4.6 mm × 250 mm, 5 µm) with a detection wavelength of 215 nm and mobile phases A (100% acetonitrile) and B (acetonitrile–water, 1 + 3, v/v) at a flow rate of 1.3 mL/min and a column temperature of 40°C. Results: The recovery study of each impurity was conducted in the range of 24 to 72 µg/mL for DRSP-related impurities and 0.2 to 0.6 µg/mL for EE-related impurities with respect to the specification limit. A linearity study was conducted over a range of 1.5 to 90 µg/mL for DRSP and DRSP-related impurities, and 0.125 to 0.75 µg/mL for EE-related impurities. A Quality by Design (QbD) study demonstrated the method’s robustness. Conclusions: As per current guidelines, a stability-indicating method has been developed for the determination of impurities in DRSP/EE film-coated tablets. A QbD-based robustness test was performed and the method was found to be robust. Highlights: An accurate, precise, stability-indicating, gradient RP-HPLC method has been developed and validated to determine DRSP, EE, and nine related impurities in tablet formulation. A QbD technique was used to establish a robustness study.